Table 2.

Meta-regressions, effect of predictors on recovery.

Name of predictor	N studies		95% CI	p	R2
Follow-up (months)	40	0.0004	[−0.0004, 0.0012]	0.297	0.51
NOS quality assessment	40	−0.0196	[−0.0802, 0.0410]	0.527	0.00
DUP median weeks	11	−0.001	[−0.0032, 0.0032]	0.368	0.00
DUP mean weeks	12	−0.0022	[−0.0101, 0.0057]	0.59	0.00
Schizophrenia-spectrum diagnosis %	21	−0.0025	[−0.0058, 0.0007]	0.130	7.75
Sex male %	31	0.006	[−0.0003, 0.0117]	0.040	10.71
Age	36	−0.0023	[−0.0173, 0.018]	0.768	0.00
Baseline positive symptoms PANSS	11	0.0126	[0.0041, 0.0207]	0.002	57.22
Baseline negative symptoms PANSS	12	−0.0037	[−0.0194, 0.012]	0.644	0.00
Functioning GAF	17	0.0014	[−0.0109, 0.0139]	0.817	0.00

Note: p < 0.002, after correction for multiple comparisons.

Abbreviations: DUP, duration of untreated psychosis; NOS, Newcastle–Ottawa Scale.